Inventor · disambiguated record
Peter Qinhua Huang
Also filed as: HUANG PETER QINHUA
33 granted patents·47 pending applications·31 citations·filing 2015–2025
95Inventor score
Files withRECURIUM IP HOLDINGS LLC58ZENO MAN INC6IMMUNOME INC5ZENO ROYALTIES & MILESTONES LLC5PFIZER4
Top patents by PatentIndex Score
80 records- 0196US11813260B1Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2023·Granted Nov 14, 2023·1 cites·20 claims
- 0295US11339162B1Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2021·Granted May 24, 2022·3 cites·30 claims
- 0393US11813259B2Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2022·Granted Nov 14, 2023·1 cites·17 claims
- 0491US11261192B2Substituted 1,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-onesRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Mar 1, 2022·5 cites·27 claims
- 0590US12186403B2Immunoconjugates and methodsIMMUNOME INC·Filed 2023·Granted Jan 7, 2025·1 cites·30 claims
- 0689US11806405B1Immunoconjugates and methodsZENO MAN INC·Filed 2022·Granted Nov 7, 2023·6 cites·42 claims
- 0789US2024180899A1Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2023·Application pending·0 cites
- 0887US12280121B2Immunoconjugates and methodsIMMUNOME INC·Filed 2024·Granted Apr 22, 2025·0 cites·12 claims
- 0987US12274754B2Immunoconjugates and methodsIMMUNOME INC·Filed 2024·Granted Apr 15, 2025·0 cites·12 claims
- 1087US11590126B2Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Feb 28, 2023·1 cites·97 claims
- 1187US11344546B2Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted May 31, 2022·1 cites·109 claims
- 1286US12285492B2Immunoconjugates and methodsIMMUNOME INC·Filed 2024·Granted Apr 29, 2025·0 cites·13 claims
- 1386US12268750B2Immunoconjugates and methodsIMMUNOME INC·Filed 2024·Granted Apr 8, 2025·0 cites·3 claims
- 1483US11065234B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Jul 20, 2021·1 cites·32 claims
- 1582US11098030B2EGFR inhibitor compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Aug 24, 2021·1 cites·13 claims
- 1682US10525036B2Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2016·Granted Jan 7, 2020·2 cites·23 claims
- 1781US11278532B2Estrogen receptor modulators for treating mutantsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Mar 22, 2022·1 cites·22 claims
- 1880US2024391924A1Substituted 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-onesRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 1979US11124518B2L,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-one analogsRECURIUM IP HOLDINGS LLC·Filed 2018·Granted Sep 21, 2021·2 cites·22 claims
- 2079US10125130B2Cycloalkyl-linked diheterocycle derivativesPFIZER·Filed 2017·Granted Nov 13, 2018·2 cites·21 claims
- 2177US10513509B2EGFR inhibitor compoundsKALYRA PHARMACEUTICALS INC·Filed 2017·Granted Dec 24, 2019·1 cites·24 claims
- 2276US10793504B2Methods for cross couplingRECURIUM IP HOLDINGS LLC·Filed 2017·Granted Oct 6, 2020·1 cites·22 claims
- 2374US11318134B2Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted May 3, 2022·0 cites·82 claims
- 2473US12049460B2EGFR inhibitor compoundsRECURIUM IP HOLDINGS LLC·Filed 2021·Granted Jul 30, 2024·0 cites·20 claims
- 2573US10676471B2Cycloalkyl-linked diheterocycle derivativesPFIZER·Filed 2019·Granted Jun 9, 2020·0 cites·2 claims
- 2673US2021330651A1Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 2772US10959989B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Mar 30, 2021·0 cites·3 claims
- 2871US10975035B2Bicyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Apr 13, 2021·0 cites·25 claims
- 2971US10493060B2Spirocyclic compoundsZENO ROYALTIES & MILESTONES LLC·Filed 2019·Granted Dec 3, 2019·1 cites·11 claims
- 3070US11999728B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2022·Granted Jun 4, 2024·0 cites·18 claims
- 3170US11065233B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Jul 20, 2021·0 cites·24 claims
- 3269USRE50643EBenzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Oct 21, 2025·0 cites·100 claims
- 3369US2022024939A1Substituted 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-onesRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 3466US12410204B2Chiral synthesis of a tertiary alcoholRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Sep 9, 2025·0 cites·19 claims
- 3566US11724971B2Process for making [1.1.1]propellaneRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Aug 15, 2023·0 cites·21 claims
- 3666US2024261295A1Combinations of wee1 inhibitors and anti-cd47 antibodiesRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 3764US2024299395A1Combination therapies comprising wee1 inhibitors and dna damage response (ddr) inhibitorsRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 3864US2024325397A1Use of combination therapy for treating cancerRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 3963US2020268714A1Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 4063US2024325412A1CombinationsRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 4163US2024335447A1Wee1 inhibitor for cancerRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 4262US2021317124A11,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-one analogsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 4362US2021115058A1Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 4461US2024408097A1Wee1 inhibitors and methods for treating cancerRECURIUM IP HOLDINGS LLC·Filed 2023·Application pending·0 cites
- 4561US2022125769A1Estrogen receptor modulators for treating mutantsRECURIUM IP HOLDINGS LLC·Filed 2022·Application pending·0 cites
- 4660US10934304B2Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2017·Granted Mar 2, 2021·0 cites·23 claims
- 4758US2019040055A1Cycloalkyl-Linked Diheterocycle DerivativesPFIZER·Filed 2018·Application pending·0 cites
- 4858US2024197743A1Wee1 compound for treating uterine serous carcinomaRECURIUM IP HOLDINGS LLC·Filed 2022·Application pending·0 cites
- 4956US2019142811A1Estrogen receptor modulatorsZENO ROYALTIES & MILESTONES LLC·Filed 2017·Application pending·0 cites
- 5056US2023167105A1Bcl-2 protein inhibitorsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
Showing the top 50 of 80 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Peter Qinhua Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →